Best for
Mobile

Posted
Advanced Medical Solutions Group plc is a medical instruments & supplies business based in the UK. Advanced Medical Solutions Group shares (AMS.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. Advanced Medical Solutions Group employs 700 staff and has a trailing 12-month revenue of around £92.9 million.
Best for
Mobile
Best for
Low-cost
Best for
All rounder
Best for
Beginners
Latest market close | N/Ap |
---|---|
52-week range | 189.5443p - 288.0336p |
50-day moving average | 233.3235p |
200-day moving average | 223.6979p |
Wall St. target price | 329.67p |
PE ratio | 36.5079 |
Dividend yield | 0.02p (0.67%) |
Earnings per share (TTM) | 6.3p |
Other fees may apply. Your capital is at risk.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Valuing Advanced Medical Solutions Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Advanced Medical Solutions Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Advanced Medical Solutions Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 37x. In other words, Advanced Medical Solutions Group shares trade at around 37x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the FTSE 250 at the end of September 2019 (19.71). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Advanced Medical Solutions Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.4323. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Advanced Medical Solutions Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Advanced Medical Solutions Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is £22 million.
The EBITDA is a measure of a Advanced Medical Solutions Group's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | £92.9 million |
---|---|
Operating margin TTM | 19.06% |
Gross profit TTM | £60.5 million |
Return on assets TTM | 4.97% |
Return on equity TTM | 7.24% |
Profit margin | 14.84% |
Book value | 0.922p |
Market capitalisation | £495.4 million |
TTM: trailing 12 months
Dividend payout ratio: 24.45% of net profits
Recently Advanced Medical Solutions Group has paid out, on average, around 24.45% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.67% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Advanced Medical Solutions Group shareholders could enjoy a 0.67% return on their shares, in the form of dividend payments. In Advanced Medical Solutions Group's case, that would currently equate to about 0.02p per share.
While Advanced Medical Solutions Group's payout ratio might seem low, this can signify that Advanced Medical Solutions Group is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 24 September 2020 (the "ex-dividend date").
Advanced Medical Solutions Group's shares were split on a 10000:1010 basis on 2 April 2002. So if you had owned 1010 shares the day before before the split, the next day you'd have owned 10000 shares. This wouldn't directly have changed the overall worth of your Advanced Medical Solutions Group shares – just the quantity. However, indirectly, the new 89.9% lower share price could have impacted the market appetite for Advanced Medical Solutions Group shares which in turn could have impacted Advanced Medical Solutions Group's share price.
Over the last 12 months, Advanced Medical Solutions Group's shares have ranged in value from as little as 189.5443p up to 288.0336p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while Advanced Medical Solutions Group's is 0.6502. This would suggest that Advanced Medical Solutions Group's shares are less volatile than average (for this exchange).
Subscribe to trending stock alerts for a chance to win
Advanced Medical Solutions Group plc, together with its subsidiaries, designs, develops, manufactures, and distributes products for the wound care, surgical, and wound closure markets in the United Kingdom, Germany, Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The Surgical segment offers topical tissue adhesives for wound closure and sealing under the LiquiBand; sutures and collagen based products for the surgical and dental markets under the RESORBA; collagens; and laparoscopic device which reduces surgical complications under the LiquiBand Fix8 brands. The Woundcare segment provides wound care platform technologies, which include alginates, foams, films, fibres, hydrogels, antimicrobial dressings, and hydrocolloids, as well as wound care products under the ActivHeal. It also sells its products under the Seal-G and Biomatlante brand names, such as Moldable Bone Graft Substitute, a biphasic calcium phosphate synthetic bone graft substitute that includes Syringes, Inserts, and In'Oss; EZ Cure, a collagen membranes; and Osteotwin, a Biocompatible Interference Resorbable Screw. The company was founded in 1991 and is headquartered in Winsford, the United Kingdom.
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.